PETS · XBRL financial data

PetMed Express financial statements, every fiscal year

The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (PETS's year ends in late March)

In thousands of dollars	FY 2021Mar 31, 2021	FY 2022Mar 31, 2022	FY 2023Mar 31, 2023	FY 2024Mar 31, 2024	FY 2025Mar 31, 2025	FY 2026Mar 31, 2026
Revenue from contracts with customers	—	—	247,569	274,095	226,972	179,021
Cost of goods and services sold	219,267	195,341	185,844	202,416	157,835	—
Gross profit	89,948	78,076	70,735	78,648	69,137	50,216
General and administrative	28,293	30,829	41,714	55,246	38,647	50,733
Total operating expenses	52,361	52,366	64,684	86,810	70,667	108,889
Operating income (loss)	37,587	25,710	6,051	(8,162)	(1,530)	(58,673)
Interest income	314	335	2,070	—	—	—
Other income (expense)	1,315	1,026	944	1,378	758	803
Income tax expense (benefit)	8,613	5,971	2,305	1,191	5,684	(73)
Net income (loss)	30,603	21,100	5,140	(7,464)	(6,271)	(57,286)
Earnings per share, basic USD per share	1.53	1.05	0.25	(0.37)	(0.30)	(2.74)
Earnings per share, diluted USD per share	1.52	1.04	0.25	(0.37)	(0.30)	(2.74)
Weighted average shares, basic thousands of shares	20,060	20,176	20,275	20,396	20,596	20,921
Weighted average shares, diluted thousands of shares	20,119	20,358	20,339	20,396	20,596	20,921

Fiscal years (PETS's year ends in late March)

In thousands of dollars	FY 2021Mar 31, 2021	FY 2022Mar 31, 2022	FY 2023Mar 31, 2023	FY 2024Mar 31, 2024	FY 2025Mar 31, 2025	FY 2026Mar 31, 2026
Cash and cash equivalents	118,718	111,080	104,086	55,296	54,720	21,412
Accounts receivable	2,587	1,913	1,740	3,283	2,317	1,908
Inventory	—	—	—	28,556	16,205	13,608
Prepaid and other current assets	4,503	4,866	4,719	6,325	5,330	6,378
Total current assets	161,187	150,995	130,431	93,648	78,871	43,564
Property and equipment, net	25,450	24,464	26,178	26,657	28,859	26,326
Right-of-use asset	—	—	0	1,432	966	512
Goodwill	—	—	0	26,658	26,658	0
Total assets	187,497	176,319	167,478	169,884	148,700	81,191
Accounts payable	39,548	27,500	25,208	37,024	23,564	20,906
Total current liabilities	44,935	33,197	57,512	72,158	62,768	52,034
Lease liability, non-current	—	—	0	995	535	42
Total liabilities	46,216	34,133	57,512	73,153	63,566	52,251
Retained earnings	134,141	130,496	91,659	71,555	66,544	9,263
Total stockholders' equity	141,281	142,186	109,966	96,731	85,134	28,940
Total liabilities and equity	187,497	176,319	167,478	169,884	148,700	81,191
Common shares outstanding (cover page) thousands of shares	20,269	20,988	21,171	20,607	21,016	21,366

Fiscal years (PETS's year ends in late March)

In thousands of dollars	FY 2021Mar 31, 2021	FY 2022Mar 31, 2022	FY 2023Mar 31, 2023	FY 2024Mar 31, 2024	FY 2025Mar 31, 2025	FY 2026Mar 31, 2026
Net income (loss)	30,603	21,100	5,140	(7,464)	(6,271)	(57,286)
Stock-based compensation	3,307	4,549	6,617	6,869	(6,586)	1,365
Depreciation and amortization	—	2,738	3,546	7,056	7,039	9,387
Net cash from operating activities	40,075	18,498	27,803	4,317	4,718	(28,394)
Purchases of property and equipment	2,432	1,752	5,260	4,511	5,113	4,615
Net cash from investing activities	(2,432)	(1,752)	(10,260)	(40,670)	(5,113)	(4,615)
Share repurchases	0	0	—	—	—	—
Dividends paid	22,687	24,384	24,537	12,437	181	21
Net cash from financing activities	(22,687)	(24,384)	(24,537)	(12,437)	(181)	(299)
Net change in cash	14,956	(7,638)	(6,994)	(48,790)	(576)	(33,308)

SIC 5912 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.

How peers are chosen

SIC 5912 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Fewer than three companies fall in that range, so the list adds same-SIC (5912) companies nearest in public float, each marked “added: same SIC”.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “year only” links to a 10-K that gives only the full year: without all three earlier quarters there is no fourth quarter to work out, and the year total is never shown as a quarter.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Petmed Express	13,079	41,015	(7,687)	21.7M	1.7 quarters	Q1 FY27 10-QJun 30, 2026
Guardian Pharmacy Servicesadded: same SIC	89,807	351,768	30,025*	not reported	—	Q2 FY26 10-QJun 30, 2026
AiXin Life Internationaladded: same SIC	21	83*	(262)*	25.0M	0.1 quarters	Q4 FY25 10-KDec 31, 2025
CVS Healthadded: same SIC	11,738,000	108,399,000	4,724,000*	1.3B	—	Q3 FY26 10-QSep 30, 2026
TREES Corp (Colorado)added: same SIC	245	3,310	99*	108.7M	—	Q3 FY24 10-QSep 30, 2024
Flowerkist Skin Care & Cosmeticsadded: same SIC	not reported	not reported	not reported	not reported	—	—
Ridgetechadded: same SIC	17,905	year only	year only	133.1M	—	Q4 FY26 20-FMar 31, 2026
111added: same SIC	510,967	year only	year only	not reported	—	Q4 FY25 20-FDec 31, 2025

Not investment advice. Not affiliated with the U.S. SEC.